Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Global Wound Care Market Continues to Grow

By HospiMedica International staff writers
Posted on 05 Jul 2015
The global wound care market will continue to expand over the long term, due to an aging population, longer life expectancies, and an increasing number of patients across all care settings, according to a new report. More...


The largest segment of the global market for wound care is that of surgical and trauma wound management, which includes wound closure, anti-infectives, wound management, moist dressings, biologic dressings, and miscellaneous treatments. Other market segments are those of negative pressure wound therapy (NWPT) and pressure relief. While several of the products within the global wound care market are mature, others, such as biological dressings and NPWT are in the infant stages of development.

The market is expected to exhibit an overall steady growth rate due to recent emphasis on wound care products and prevention, and a growing focus on special populations such as those of diabetics and the obese. Some of the reasons for the projected expansion of the market is that patients today have more complex coexisting illnesses such as diabetes, heart failure, obesity, pulmonary and vascular diseases, immobility issues, and chronic wounds.

Advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth in the market. Another reason is paradigm shift regarding the use of dressing materials, with a view of utilizing them in the same way as drugs, with specific actions, interactions, contraindications, indications, and side effects. According to the report, published annually by Kalorama Information (New York, NY, USA), South Korea, Australia, Brazil, India, and China together represent a combined USD 3.1 billion market opportunity for wound care device makers.

“A worldwide economic slowdown did not seem to have a big impact on this market, demand for therapies remained high,” said Bruce Carlson, Publisher of Kalorama Information. “Growth should continue to come from new therapies, which will result in decreased healing times and subsequent cost savings.”

Related Links:

Kalorama Information



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.